Chronic nasopharyngitis is a slow-progressing chronic inflammation often coexisting with adjacent organ or systemic diseases, such as sinusitis, adenoid remnants or retention abscesses, and pharyngeal bursitis, which may cause prolonged irritation and inflammation of the nasopharynx. Additionally, it is closely related to certain diseases or symptoms of unknown causes, such as endocrine disorders, gastrointestinal dysfunction, wind-dampness arthritis, prolonged low-grade fever, headache, dizziness, fetid mouth odor, and impaired sense of smell. When chronic nasopharyngitis is cured, some diseases or symptoms may significantly improve or be completely resolved.

bubble_chart Clinical Manifestations

Nasopharyngeal dryness and discomfort, with viscous secretions that are difficult to expectorate, leading to frequent coughing often accompanied by nausea. In severe cases, symptoms such as hoarseness, sore throat, headache, dizziness, lack of strength, indigestion, and low-grade fever may occur, either systemically or locally. Nasopharyngeal examination reveals chronic congestion of the mucous membrane, hyperplasia and thickening, covered with secretions or dry crusts.

bubble_chart Diagnosis

Due to the slow progression of the disease and the concealed location of the lesions, early diagnosis is often difficult to establish. Based on clinical manifestations, a thorough examination of the pharynx is conducted. For patients with a sensitive gag reflex or those unable to cooperate with the examination, fiberoptic nasopharyngoscopy is employed. A biopsy is performed when necessary to confirm the diagnosis and rule out nasopharyngeal tumors. Skull base X-rays and cranial CT or MRI scans are helpful for differential diagnosis.

Identify the cause of the disease and treat the disease cause. Additionally, strengthening exercise, enhancing constitution, and improving the body's resistance are crucial. Administer systemic or local medication based on the condition. Special attention should be paid to nasal drops, commonly using 0.5-1% chloramphenicol and 0.5% cortisone solutions or other formulations. These solutions, when administered through the nasal cavity to the nasopharynx, can achieve significant therapeutic effects.